Chronic pain, by definition, is difficult to manage, but a new study by UCSF scientists shows how a cell therapy might one day be used not only to quell some common types of persistent and difficult-to-treat pain, but also to cure the conditions that give rise to them.
April 18, 2012
Scientists at the UCSF-affiliated Gladstone Institutes announced a research breakthrough in mice that one day may help doctors restore hearts damaged by heart attacks — by converting scar-forming cardiac cells into beating heart muscle.
March 15, 2012
Scientists have gained insight into how second-hand tobacco smoke damages the earliest stages of human embryonic development.
February 15, 2012
A UCSF stem cell study conducted in mice suggests a novel strategy for treating damaged cardiac tissue in patients following a heart attack, which an estimated 785,000 Americans will experience this year.
May 06, 2011
Three UCSF scientists have received grants from the California Institute for Regenerative Medicine to advance their investigations of treatment strategies for degenerative muscle diseases, such as muscular dystrophy, and heart disease, and to determine why human embryonic stem cells are susceptible to forming tumors.
February 09, 2011
UCSF celebrates the opening of an architecturally unique stem cell building, a milestone in the history of UCSF’s pioneering stem cell research program, one of the largest and most comprehensive of its kind in the United States.
January 31, 2011
Ray and Dagmar Dolby this week donated $20 million to the University of California, San Francisco to provide funding for a stem cell building on the Parnassus campus.
January 18, 2011
UCSF researchers have tackled a decade-long scientific conundrum, and their discovery is expected to lead to significant advances in using stem cells to treat genetic diseases before birth.
December 16, 2010
UCSF researchers have shown for the first time that the human fetal immune system arises from an entirely different source than the adult immune system, and is more likely to tolerate than fight foreign substances in its environment.
December 14, 2010
For patients with glioma, the most common primary brain tumor, new findings may explain why current therapies fail to eradicate the cancer. A UCSF-led team of scientists has identified for the first time that progenitor rather than neural stem cells underly a type of glioma called oligodendroglioma.